Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fansimef

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Mefloquine levels were compared between Plasmodium falciparum malaria patients with sensitive response and those with treatment… Expand
Is this relevant?
1992
1992
At a time when Fansimef, the fixed combination of mefloquine, sulfadoxine and pyrimethamine was considered for prophylaxis of… Expand
Is this relevant?
1991
1991
Two simple, precise, and selective high-performance liquid chromatographic methods are described for the simultaneous… Expand
Is this relevant?
1990
1990
A double-blind comparative study of Fanismef-mefloquine/sulfadoxine/pyrimethamine (MSP) and Lariam-mefloquine (MEF) for the… Expand
Is this relevant?
1989
1989
A single dose pharmacokinetic study of a combined antimalarial formulation of mefloquine, sulphadoxine and pyrimethamine… Expand
Is this relevant?
1988
1988
A randomized double blind study in long term malaria chemoprophylaxis was performed to compare the tolerability of Fansimef (1… Expand
Is this relevant?
1987
1987
Fansimef is a new oral schizonticide which contains pyrimethamine (P), sulfadoxine (S) and mefloquine (M) in a weight ratio of 1… Expand
Is this relevant?
1987
1987
Fansimef is a combination of 250 mg mefloquine (base), 500 mg sulfadoxine, and 25 mg pyrimethamine per tablet. One hundred and… Expand
Is this relevant?
1987
1987
Fansimef is a new antimalarial combination containing pyrimethamine, sulfadoxine and mefloquine in the weight proportions 1 + 20… Expand
Is this relevant?
1985
1985
A double-blind, randomized phase I clinical trial was carried out to compare Fansimef (a fixed-dose combination of mefloquine… Expand
Is this relevant?